ALLK(Delisted)
AllakosยทNASDAQ
--
--(--)
ALLK Profile
Allakos Inc.
A clinical stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases
149 Commonwealth Dr Suite 1090, Menlo Park, California 94025
--
Allakos Inc., was incorporated in Delaware in March 2012. The company is a clinical-stage biotechnology company that develops therapies for immunomodulatory receptors present on immune effector cells associated with allergies, inflammation and proliferative diseases. AK006 targets Siglec-6, an inhibitory receptor selectively expressed on mast cells, a widely distributed white blood cell in the body that plays a central role in the inflammatory response.
